London loses another listed company as pharma riser goes private

The AIM market has continued to shrink, with Redx Pharma being the latest company to pull away from the London Stock Exchange’s scale-up public market. In a statement today, the Cheshire-based drug developer said it would be seeking to becoming a private company, citing liquidity constraints from the AIM market as holding back its valuation. [...]